register

News & Trends - MedTech & Diagnostics

TGA pushes for fee increases despite MedTech opposition

Health Industry Hub | July 1, 2020 |

MedTech News: The Therapeutic Goods Administration (TGA) is set to increase its fees by 1.95% in its 2020-2021 financial year.

The TGA decided on the fee increase tied to consumer price and wage inflation, despite a consultation revealing opposition from the MedTech industry.
 
In January 2020, TGA held a consultation to gather industry feedback on three options for changing its fees and charges. TGA stated its preferred option was a 1.95% increase, in line with an indexation factor tied to indices of consumer prices and wages. The agency also discussed maintaining its 2019-2020 fee structure or increasing its rates by 4.3%.

Around half of the responses to the consultation supported TGA’s preferred option. One medicine industry body noted it would have supported a 1.95% increase if not for the financial impact of COVID-19 on its members.

Stronger opposition came from the MedTech sector, where two industry bodies opposed any fee rises “due to the increasing cost of doing business and inability to pass such costs to their customers to remain competitive in the market.”
 
The Assistive Technology Suppliers Australia (ATSA) was among the opposition. “In percentage terms the proposed increases, in part due to the $10 rounding factor, is well above any [consumer price index] growth. Despite the impact of the $10 rounding approach from previous years that is compounding, annual increases have been continually applied. Only a monopoly situation can get away with such increases,” ATSA wrote in its feedback.
 
Other MedTech groups took a different position. The Medical Technology Association of Australia (MTAA) voiced support for raising fees by 1.95%, while also stating “it is important to also recognise that increases on fees and charges for medical device sponsors come on top of an industry already being punished under fairly dramatic price cuts by the same Government through the cuts in the Prostheses List.”


News & Trends - MedTech & Diagnostics

Medtronic partners with local researchers in stroke trial

Medtronic partners with local researchers in stroke trial

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: Endovascular thrombectomy has been shown to be more effective in reducing disability than medical therapy alone […]

More


News & Trends - Pharmaceuticals

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Ministers reflect on the reforms and complexities facing the healthcare system

Health Industry Hub | March 1, 2024 |

Pharma News: Mark Butler MP, Federal Minister for Health, and Senator Anne Ruston, Shadow Minister for Health, reflected on the […]

More


News & Trends - Pharmaceuticals

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Gilead seeks funding of CAR T-cell therapy in follicular lymphoma

Health Industry Hub | March 1, 2024 |

Pharma News: Gilead has applied to the Medical Services Advisory Committee (MSAC) for funding of its cutting-edge CAR T-cell therapy, […]

More


News & Trends - MedTech & Diagnostics

Should private insurers face scrutiny for soaring profits while patients foot the bill? MTAA, Private Healthcare Australia

Should private health insurers face scrutiny for soaring profits while patients foot the bill?

Health Industry Hub | March 1, 2024 |

MedTech & Diagnostics News: In a clash of interests, the Medical Technology Association of Australia (MTAA) has once again urged […]

More


This content is copyright protected. Please subscribe to gain access.